Could blocking key epigenetic androgen receptor co-regulators be a potential new treatment for advanced #ProstateCancer? Prof. Nigel Mongan @uniofnottingham.bsky.social and team share promising novel findings in @moloncology.bsky.social. Grab a ☕ and read: doi.org/10.1002/1878...

📣 Join a qualitative interview study on treatment decisions in metastatic hormone sensitive prostate cancer. Seeking medical and clinical oncologists, urologists, and prostate cancer nurse specialists. More details + sign up ➡️ buff.ly/q3iFHCm @annabellesouth.bsky.social @mrcctu.bsky.social

Could MRI image quality limit the performance of deep learning models in #ProstateCancer diagnosis? Validated by data from our funded research, Prof Ivo Schoots & Eduardo Pooch unveil new findings in European Journal of Radiology Artificial Intelligence. Grab a ☕ & read: doi.org/10.1016/j.ej...

[1/7] We’re proud to highlight this important work alongside The British Nuclear Medicine Society for #ProstateCancerAwarenessMonth Nuclear Medicine has long played a role in prostate cancer imaging and management and is now driving key advances in patient care. Read more ⬇️

📢 Are you an ambitious medical oncologist aiming to transition to a Professorial position within 5 years? Thanks to the generous support of Trailfinders we are awarding a prestigious £2M fellowship an outstanding clinical leader. Deadline: 20 April 👉

The late Prof Val Macaulay led pioneering research at University of Oxford investigating an IGF-blocking treatment for early-stage #ProstateCancer. The WINGMEN trial investigated whether the treatment could reduce IGF levels and slow cancer growth. 📙Read more: prostatecanceruk.org/research/res...

📢 NEW FUNDING OPPORTUNITY: We are awarding a prestigious £2M fellowship to an ambitious academic prostate cancer medical oncologist The fellowship will support the transition to a research leadership position within the next 5 years ⏱️ 20 April 2026 👉

Hear from leading experts at the Specialists Conference! 📆 25–26 March 🕒 9am–12:30pm 📍 Online (Teams) Featuring Elizabeth Bancroft (BRCA), Nikhil Vasdev (AI) & patient voices from Steve and Wayne. Free to attend ➡️ buff.ly/CiGDxua #ProstateCancerAwarenessMonth #CPD

Could a tool combining genetics with family history improve #ProstateCancer screening? An international team including multiple Prostate Cancer UK funded researchers detail the findings of the ProGRESS study in @natcancer.nature.com. Grab a ☕ and read: www.nature.com/articles/s43...

The March edition of Research News is here! Learn about: 🆕 Our new Black Health Equity strategy 💰 New funding opportunities 💙 How our research makes a real impact for men with #ProstateCancer 📰 Recent prostate cancer research articles Read here: buff.ly/8Sd6vxh

📢 NEW FUNDING OPPORTUNITY: We are awarding a prestigious £2M fellowship to an ambitious academic prostate cancer medical oncologist The fellowship will support the transition to a research leadership position within the next 5 years Deadline: 20 April 2026 👉 prostatecanceruk.org/trailfinders...

Don't miss your chance to join our webinar! Discover how we're partnering with Movember to improve the sexual wellbeing of men with prostate cancer and learn about a new funding call. 📆 25 March ⏰ 6:00pm - 7:15pm 📍 Online via Teams Sign up now ➡️ buff.ly/keMZU5c

Dr @alison-tree.bsky.social led the TRAP trial at The Royal Marsden, exploring targeted SBRT, a precise radiotherapy, for men with advanced #ProstateCancer. The trial looked at whether SBRT could delay chemotherapy and maintain quality of life. 📙 Read more: prostatecanceruk.org/research/res...

Could inhibiting c-FLIP enhance the effectiveness of docetaxel in men with #ProstateCancer? Exciting new research from Cardiff University, led by Prof Richard Clarkson and Dr Daniel Turnham, has been published in British Journal of Cancer. Grab a ☕ and read: doi.org/10.1038/s414...

📢The Career Acceleration Fellowships are now OPEN! 🚀 This scheme offers up to £350K over 3-4 years to early career prostate cancer researchers to advance their careers and build collaborations. Apply now buff.ly/0nePUKP Deadline: 26 May 2026, 1pm

We are awarding a prestigious £2M fellowship to an ambitious academic prostate cancer medical oncologist This fellowship will support the awardee’s transition to a research leadership position within the next 5 years. Opens 16 March Find out more here: buff.ly/AAQ9kFm

Prof Gert Attard @ucl.ac.uk leads a team improving treatment for men with advanced #ProstateCancer. Since 2012, we’ve supported his team in identifying biomarkers that guide more personalised treatment, improving outcomes and reducing side effects. 📙 Read more: bit.ly/4skoqFb

Updated guidance is now available for the Career Acceleration Fellowships! Visit our website for details: buff.ly/0nePUKP Call opens 10 March 2026 contact us via email to discuss your application

Could expanding SBRT to pelvic lymph nodes improve outcomes for men with high-risk #ProstateCancer? @profemmahall.bsky.social and Dr Angela Pathmanathan @icr.ac.uk, funded by Prostate Cancer UK, detail their trial approach in ctRO. Grab a ☕ and read: www.ctro.science/article/S240...

😁 We're delighted @arteraai.bsky.social are sponsoring From Ideas to Innovation. 🏥 Global leaders in precision medicine, leveraging multimodal intelligence to personalise cancer care. 🗣️ Speak to Artera's Director of Product Management at the event to hear more prostatecanceruk.org/research/for...

How does FUS regulate androgen receptor activity during #ProstateCancer progression? Researchers @imperialsandc.bsky.social & @universityofessex.bsky.social, including Dr Greg Brooke, Dr Damien Leach & Prof Charlotte Bevan, share new findings in Oncogene. Grab a ☕ & read: doi.org/10.1038/s413...

We’re teaming up with Movember to improve the sexual health & wellbeing of men with prostate cancer. Sign up to our webinar and be among the first to hear about a new funding call! 📅 25 March ⏰ 6 - 7:15 pm 📍 Online on Teams Find out more ➡️https://buff.ly/pP1w5b0

📢 Final week to apply for the @acmedsci.bsky.social Starter Grants for Clinical Lecturers, in partnership with @prostatecanceruk.bsky.social. Don't miss the 16:00 BST deadline on 26 February 2026! More details 👉 acmedsci.ac.uk/starter-grants #researchcareers #researchfunding #prostatecancer

Could AI predict outcomes and side-effects of radiotherapy in men with #prostatecancer? Prostate Cancer UK funded Prof. Bill Nailon and Prof. Duncan McLaren @edinburgh-uni.bsky.social detail how they'll answer this question in BMJ Open. Grab a ☕ and read: bmjopen.bmj.com/content/16/2...

The February edition of Research News is here! Discover more about: 🔬 An exciting research project. 💸 Our new funding committee chairs. 💙 Our updated Research Impact webpages. 🏆 Researcher achievements. 💰 Funding opportunities. 📖 Read it here: buff.ly/azyVGlK

💻 Prostate Cancer UK Online Learning Free courses, webinars & resources to build your knowledge and earn self-accredited CPD. Flexible, practical learning for busy health professionals. ➡️ buff.ly/gm2hkMG #ProstateCancer #CPD

📢 We’re supporting @acmedsci.bsky.social to provide up to £40K over 2 years to Clinical Lecturers looking to develop and strengthen their research careers. Funding deadline is 26 February 2026. Visit AMS website for more info 👉 acmedsci.ac.uk/starter-grants #CareerDevelopment #ResearchFunding

Can AI learn to detect aggressive #ProstateCancer on MRI with limited expert input? A team, including Prostate Cancer UK–funded Profs. Hashim Ahmed & Mark Emberton, publish findings in @europeanradiology.bsky.social powered by data from our funded research. Grab a ☕ & read: doi.org/10.1007/s003...

📢 Do you know any rising stars⭐ in prostate cancer research? 🔬 Our Career Acceleration Fellowships offer up to £350k to help early career researchers pursue their own research goals and become future leaders in the field. Share with your team today!

Professor Jonathan Coulter @qubelfastofficial.bsky.social leads a research team developing innovative cancer therapeutics. Since 2021, we’ve supported his team in creating an implant that releases gold nanoparticles that sensitise #ProstateCancer to radiotherapy. 📙 Read more: buff.ly/vteN8gz

💻 Join our free online Specialists Conference on 25–26 March for the latest updates in prostate cancer care. Busy on the day? No worries — we’ll send you the recordings. ➡️ More details here: bit.ly/3EaVj3i #prostatecancer #professionaldevelopment #secondarycare

[1/10] 🧵 How does IGF-1 help cancer cells evade the immune system? Let's unpack the results observed in a recently published article in Scientific Reports by a team including Prostate Cancer UK funded Professor Valentine Macaulay and Professor Ian Mills. bsky.app/profile/did:...

Could molecular profiling of circulating tumour cells (CTCs) improve clinical management of #ProstateCancer? Progress on this topic is reviewed by a team including Prostate Cancer UK funded Professor Yong-Jie Lu @qmbci.bsky.social in @natrevurol.nature.com. Grab a ☕ and read: bit.ly/46ti2CJ

📢 Seize the opportunity to boost your future research career as a Clinical Lecturer! Thanks to @prostatecanceruk.bsky.social partnership with @acmedsci.bsky.social, you can apply for a Starter Grant by 26 February 2026. Learn more 👉 acmedsci.ac.uk/starter-grants #researchfunding #prostatecancer

⏰ 12 days to go: CRSG proposal deadline 💡 Got a new trial idea to improve outcomes for men with prostate cancer? Get early guidance and feedback from the CRSG. 🗓 Deadline: 4pm, Fri 13 Feb

Could GALNT7 be a promising therapeutic target for #ProstateCancer? A team led by Dr Jennifer Munkley @newcastleuni.bsky.social explores the enzyme's role & emerging strategies to inhibit its activity, writing in Expert Opinion on Therapeutic Targets. Grab a ☕ & read: doi.org/10.1080/1472...

📢 Are you a Clinical Lecturer looking to develop and strengthen your research career? The @acmedsci.bsky.social Starter Grants funding call is now OPEN. Deadline: 26 February 2026. More details 👉 acmedsci.ac.uk/starter-grants #CareerDevelopment #ResearchFunding

The January edition of Research News is here! Find out about: 🎯 How we measure the success of our funded research 🥼 UK Prostate Cancer Clinical Research Strategy Group 🧪 Research funding opportunities 📖 External workshops Read here: buff.ly/l43rtlW

Coming soon! 📢 Applications for our Career Acceleration Fellowships open in March. We’re offering up to £350K over 3-4 years to support early career prostate cancer researchers to advance their career and build collaborations. 🚨Find out more here: buff.ly/E2yRcy8

Huge congratulations to @mitosrus.bsky.social and the team @cruk-si.bsky.social for this well deserved recognition 👏

💊 NHS England expands access to abiraterone for high-risk localised & locally advanced prostate cancer ⏰ Clinicians: REVIEW diagnoses from the last 12 weeks to ensure eligible patients start treatment before they “time out” of eligibility. More info ➡️ buff.ly/qSao7sk

Could androgen-regulated amyloid precursor protein processing drive #ProstateCancer development? A team including Prostate Cancer UK Career Acceleration Fellow Dr Rachel Barker @bristoluni.bsky.social share a systematic review in Curr. Issues Mol. Biol. Grab a ☕ and read: doi.org/10.3390/cimb...

🗓️ Just 3 months to go until From Ideas to Innovation! 🚄 Book your travel now - tickets are cheaper & more options. 💸 Travel may be covered by your Prostate Cancer UK grant. 🎟️ Travel bursaries available - first come, first served. More info 👇 prostatecanceruk.org/research/for...

⏰ Time's ticking ⏰ Enhance prostate cancer care and support with our dynamic Improvement Programmes team. 🚀 Final call to be a part of our Clinical Champions Cohort 5 🌟 Apply now:

⏰ 1 month to go: CRSG proposal deadline 💡 Got a new trial idea to improve outcomes for men with prostate cancer? 🗓 Deadline: 4pm, Fri 13 Feb ⤵️Use our form & submit your proposal below.

🎉 BREAKING NEWS Abiraterone is now approved for NHS use in England for men with high-risk localised or locally advanced prostate cancer, bringing England in line with Wales & Scotland. Stay tuned — we’ll share more on what this means for you and your patients next week. Read more: buff.ly/jRDKPrv

Could targeted alpha therapy be an effective treatment for advanced #ProstateCancer? An international team, including Prostate Cancer UK-funded researcher Dr Victoria Dunne @qubelfastofficial.bsky.social, publish new findings in Scientific Reports. Grab a ☕ & read: doi.org/10.1038/s415...

Take on our step challenge, March the Month, this March. Walk 11,000 steps a day throughout March for the over 11,000 men who die of #ProstateCancer every year. Sign up now 👉 bit.ly/44HPo01

The UK NSC is currently running a public consultation on its draft recommendation for prostate cancer screening. We are encouraging you to review the proposal and submit your views to help shape the final recommendation. More details here ➡️

⏰Reminder: CRSG proposal deadline approaching 💡Got a new trial idea to improve outcomes for men with prostate cancer? Use our form & submit your proposal. Deadline: 4pm, Fri 13 Feb 🔗https://buff.ly/W0foIBz